310
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Occurrence and Genomic Characteristics of Hypervirulent Klebsiella pneumoniae in a Tertiary Care Hospital, Eastern India

, ORCID Icon & ORCID Icon
Pages 2191-2201 | Received 08 Feb 2023, Accepted 29 Mar 2023, Published online: 13 Apr 2023

References

  • Farmer J, Farmer M, Holmes B. The Enterobacteriaceae: general characteristics. Borriello S, Murray PR, Funke G, editors. In: Topley and Wilson’s Microbiology and Microbial Infections. Vol. 2, 10th. Wiley, UK; 2005: 1317–1355.
  • Procop GW, Church DL, Hall GS, et al. The Enterobacteriaceae- Taxonomy of the Enterbacteriaceae. In: Koneman’s Color Atlas and Textbook of Diagnostic Microbiology. 7th. Wolters Kluwer; 2017:269–271
  • Abbott SL. Klebsiella, Enterobacter, Citrobacter, Serratia, Plesiomonas, and Other Enterobacteriaceae. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of Clinical Microbiology. 9th ed. Washington, D.C: ASM Press; 2009:698–711.
  • Rodriguez-Medina N, Barrios-Camacho H, Duran-Bedolla J, Garza-Ramos U. Klebsiella variicola: an emerging pathogen in humans. Emerg Microbes Infect. 2019;8:973–988. doi:10.1080/22221751.2019.1634981
  • Ejaz H, Wang N, Wilksch JJ, et al. Phylogenetic Analysis of Klebsiella pneumoniae from hospitalized children, Pakistan. Emerg Infect Dis. 2017;23:1872–1875. doi:10.3201/eid2311.170833
  • Fourie JL, Claassen FM, Myburgh JJ. Causative pathogens and antibiotic resistance in community-acquired urinary tract infections in central South Africa. S Afr Med J. 2021;111:124–128. doi:10.7196/SAMJ.2021.v111i2.14905
  • Rhodes J, Jorakate P, Makprasert S, et al. Population-based bloodstream infection surveillance in rural Thailand, 2007-2014. BMC Public Health. 2019;19(Suppl3):521. doi:10.1186/s12889-019-6775-4
  • Kwan CW, Onyett H. Community-acquired urinary tract pathogens and their resistance patterns in hospitalized children in southeastern Ontario between 2002 and 2006. Paediatr Child Health. 2008;13:759–762. doi:10.1093/pch/13.9.759
  • Gordon KA, Jones RN; SENTRY Participant Groups (Europe, Latin America, North America). Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagn Microbiol Infect Dis. 2003;45:295–301. doi:10.1016/s0732-8893(02)00467-4
  • Mohanty S, Kapil A, Dhawan B, Das BK. Bacteriological and antimicrobial susceptibility profile of soft tissue infections from Northern India. Indian J Med Sci. 2004;58(1):10–15.
  • Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998–2004). Diagn Microbiol Infect Dis. 2007;57(1):7–13. doi:10.1016/j.diagmicrobio.2006.05.009
  • Liu Y-C. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med. 1986;146(10):1913–1916. doi:10.1001/archinte.1986.00360220057011
  • Wang J-H, Liu Y-C, Lee SS-J, et al. Primary Liver Abscess Due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis. 1998;26(6):1434–1438. doi:10.1086/516369
  • Cheng DL, Liu YC, Yen MY, Liu CY, Wang RS. Septic metastatic lesions of pyogenic liver abscess. Their association with Klebsiella pneumoniae bacteremia in diabetic patients. Arch Intern Med. 1991;151:1557–1559.
  • Shon AS, Bajwa RP, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence. 2013;4:107–118. doi:10.4161/viru.22718
  • Zhang Y, Zhao C, Wang Q, et al. High prevalence of hypervirulent Klebsiella pneumoniae infection in China: geographic distribution, clinical characteristics, and antimicrobial resistance. Antimicrob Agents Chemother. 2016;60:6115–6120. doi:10.1128/AAC.01127-16
  • Li W, Sun G, Yu Y, et al. Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China. Clin Infect Dis. 2014;58:225–232. doi:10.1093/cid/cit675
  • Guo Y, Wang S, Zhan L, et al. Microbiological and clinical characteristics of hypermucoviscous Klebsiella pneumoniae isolates associated with invasive infections in China. Front Cell Infect Microbiol. 2017;7:24. doi:10.3389/fcimb.2017.00024
  • Garza-Ramos U, Barrios-Camacho H, Moreno-Domínguez S, et al. Phenotypic and molecular characterization of Klebsiella spp. isolates causing community-acquired infections. New Microbes New Infect. 2018;23:17–27. doi:10.1016/j.nmni.2018.02.002
  • Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, Chang SC. Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis. 2007;45:284–293. doi:10.1086/519262
  • Turton JF, Baklan H, Siu LK, Kaufmann ME, Pitt TL. Evaluation of a multiplex PCR for detection of serotypes K1, K2 and K5 in Klebsiella sp. and comparison of isolates within these serotypes. FEMS Microbiol Lett. 2008;284:247–252. doi:10.1111/j.1574-6968.2008.01208.x
  • Russo TA, Olson R, Fang CT, et al. Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J Clin Microbiol. 2018;56:e00776–18. doi:10.1128/JCM.00776-18
  • Turton JF, Perry C, Elgohari S, Hampton CV. PCR characterization and typing of Klebsiella pneumoniae using capsular type-specific, variable number tandem repeat and virulence gene targets. J Med Microbiol. 2010;59:541–547. doi:10.1099/jmm.0.015198-0
  • Zhan L, Wang S, Guo Y, et al. Outbreak by hypermucoviscous Klebsiella pneumoniae ST11 isolates with carbapenem resistance in a tertiary hospital in China. Front Cell Infect Microbiol. 2017;7:182. doi:10.3389/fcimb.2017.00182
  • Mohanty S, Mittal G, Gaind R. Identification of carbapenemase-mediated resistance among Enterobacteriaceae bloodstream isolates: a molecular study from India. Indian J Med Microbiol. 2017;35:421–425. doi:10.4103/ijmm.IJMM_16_386
  • Cui X, Zhang H, Du H. Carbapenemases in Enterobacteriaceae: detection and antimicrobial therapy. Front Microbiol. 2019;10:1823. doi:10.3389/fmicb.2019.01823
  • Lan P, Jiang Y, Zhou J, Yu Y. A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae. J Glob Antimicrob Resist. 2021;25:26–34. doi:10.1016/j.jgar.2021.02.020
  • Zhou Q, Wu C, Zhou P, et al. Characterization of hypervirulent and carbapenem-resistant K. pneumoniae isolated from neurological patients. Infect Drug Resist. 2023;16:403–411. doi:10.2147/IDR.S392947
  • Beyrouthy R, Dalmasso G, Birer A, Robin F, Bonnet R. Carbapenem resistance conferred by OXA-48 in K2-ST86 hypervirulent Klebsiella pneumoniae, France. Emerg Infect Dis. 2020;26:1529–1533. doi:10.3201/eid2607.191490
  • Albasha AM, Osman EH, Abd-Alhalim S, Alshaib EF, Al-Hassan L, Altayb HN. Detection of several carbapenems resistant and virulence genes in classical and hyper-virulent strains of Klebsiella pneumoniae isolated from hospitalized neonates and adults in Khartoum. BMC Res Notes. 2020;13:312. doi:10.1186/s13104-020-05157-4
  • Remya P, Shanthi M, Sekar U. Occurrence and characterization of hyperviscous K1 and K2 serotype in Klebsiella pneumoniae. J Lab Physicians. 2018;10:283–288. doi:10.4103/JLP.JLP_48_18
  • Shankar C, Veeraraghavan B, Nabarro LEB, Ravi R, Ragupathi NKD, Rupali P. Whole genome analysis of hypervirulent Klebsiella pneumoniae isolates from community and hospital acquired bloodstream infection. BMC Microbiol. 2018;18:6. doi:10.1186/s12866-017-1148-6
  • Banerjee T, Wangkheimayum J, Sharma S, Kumar A, Bhattacharjee A. Extensively drug-resistant hypervirulent Klebsiella pneumoniae from a series of neonatal sepsis in a tertiary care hospital, India. Front Med. 2021;8:645955. doi:10.3389/fmed.2021.645955
  • Mukherjee S, Naha S, Bhadury P, et al. Emergence of OXA-232-producing hypervirulent Klebsiella pneumoniae ST23 causing neonatal sepsis. J Antimicrob Chemother. 2020;75:2004–2006. doi:10.1093/jac/dkaa080
  • Collee JG, Duguid JP, Marmion BP, Simmons A. Laboratory strategy in the diagnosis of infective syndromes. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie & McCartney Practical Medical Microbiology. 14 ed. Edinburgh: Churchill Livingstone; 1996:53–94.
  • Garcia LS, Isenberg HD, editors. Clinical Microbiology Procedures Handbook. Second ed. Washington DC: ASM Press; 2007.
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 29 ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2019.
  • Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–281. doi:10.1111/j.1469-0691.2011.03570.x
  • World Health Organization. Prevention of Hospital-Acquired Infections: A Practical Guide. 2. WHO/CDS/CSR/EPH/2002.12; 2002.
  • Bora A, Hazarika NK, Shukla SK, Prasad KN, Sarma JB, Ahmed G. Prevalence of blaTEM, blaSHV and blaCTX-M genes in clinical isolates of Escherichia coli and Klebsiella pneumoniae from Northeast India. Indian J Pathol Microbiol. 2014;57:249–254. doi:10.4103/0377-4929.134698
  • Delle Rose D, Sordillo P, Gini S, et al. Microbiologic characteristics, and predictors of mortality in bloodstream infections in intensive care unit patients: a 1-year, large, prospective surveillance study in 5 Italian hospitals. Am J Infect Control. 2015;43:1178–1183. doi:10.1016/j.ajic.2015.06.023
  • Bhardwaj V, Annapandian VM, Sinazer AR, Alva A, Prasad S. Incidence, risk factors and clinical outcomes of patients with hypermucoviscoid Klebsiella in a Tertiary Intensive Care Unit. J Glob Infect Dis. 2020;12:202–207. doi:10.4103/jgid.jgid_145_19
  • Xu M, Fu Y, Kong H, et al. Bloodstream infections caused by Klebsiella pneumoniae: prevalence of blaKPC, virulence factors and their impacts on clinical outcome. BMC Infect Dis. 2018;18:358. doi:10.1186/s12879-018-3263-x
  • Jung SW, Chae HJ, Park YJ, et al. Microbiological and clinical characteristics of bacteraemia caused by the hypermucoviscosity phenotype of Klebsiella pneumoniae in Korea. Epidemiol Infect. 2013;141:334–340. doi:10.1017/S0950268812000933
  • Kim YJ, Kim SI, Kim YR, et al. Virulence factors and clinical patterns of hypermucoviscous Klebsiella pneumoniae isolated from urine. Infect Dis. 2017;49:178–184. doi:10.1080/23744235.2016.1244611
  • Ikeda M, Mizoguchi M, Oshida Y, et al. Clinical and microbiological characteristics and occurrence of Klebsiella pneumoniae infection in Japan. Int J Gen Med. 2018;11:293–299. doi:10.2147/IJGM.S166940
  • Rastegar S, Moradi M, Kalantar-Neyestanaki D, Ali Golabi D, Hosseini-Nave H. Virulence factors, capsular serotypes and antimicrobial resistance ofhypervirulentKlebsiella pneumoniae and classical Klebsiella pneumoniae in southeast Iran. Infect Chemother. 2019. doi:10.3947/ic.2019.0027
  • Rafat C, Messika J, Barnaud G, Dufour N, Magdoud F. Hypervirulent Klebsiella pneumoniae, a 5-year study in a French ICU. J Med Microbiol. 2018;67:1083–1089. doi:10.1099/jmm.0.000788
  • Peirano G, Pitout JD, Laupland KB, Meatherall B, Gregson DB. Population-based surveillance for hypermucoviscosity Klebsiella pneumoniae causing community-acquired bacteremia in Calgary, Alberta. Can J Infect Dis Med Microbiol. 2013;24:e61–e64. doi:10.1155/2013/828741
  • Guo S, Xu J, Wei Y, Xu J, Li Y, Xue R. Clinical and molecular characteristics of Klebsiella pneumoniae ventilator-associated pneumonia in mainland China. BMC Infect Dis. 2016;16:608. doi:10.1186/s12879-016-1942-z
  • Shen M, Chen X, He J, et al. Antimicrobial resistance patterns, sequence types, virulence and carbapenemase genes of carbapenem-resistant Klebsiella pneumoniae clinical isolates from a Tertiary Care Teaching Hospital in Zunyi, China. Infect Drug Resist. 2023;16:637–649. doi:10.2147/IDR.S398304
  • Chen Q, Zhou JW, Qiu CN, et al. Antimicrobial susceptibility and microbiological and epidemiological characteristics of hypermucoviscous Klebsiella pneumoniae strains in a tertiary hospital in Hangzhou, China. J Glob Antimicrob Resist. 2018;15:61–64. doi:10.1016/j.jgar.2018.05.025